Viewing Study NCT06140732


Ignite Creation Date: 2025-12-24 @ 9:29 PM
Ignite Modification Date: 2025-12-25 @ 7:14 PM
Study NCT ID: NCT06140732
Status: RECRUITING
Last Update Posted: 2023-11-20
First Post: 2023-11-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Sponsor: Xuanwu Hospital, Beijing
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module